首页> 外国专利> METHOD FOR PREDICTING HEMORRHAGIC COMPLICATIONS IN THERAPY WITH INDIRECT ANTICOAGULANTS

METHOD FOR PREDICTING HEMORRHAGIC COMPLICATIONS IN THERAPY WITH INDIRECT ANTICOAGULANTS

机译:间接抗凝剂在治疗中出血并发症的预测方法

摘要

The method for predicting the hemorrhagic complications in the therapy with the indirect anticoagulants comprises the individualization of the therapy. Prior to anticoagulant therapy, the gene polymorphism of VKORC1 gene is studied. The genotype AA1639 and GA1639 one suggests that the daily dose of Warfarin should be reduced.
机译:用间接抗凝剂预测治疗中出血并发症的方法包括治疗的个体化。在抗凝治疗之前,研究了VKORC1基因的基因多态性。基因型AA1639和GA1639建议华法林的每日剂量应减少。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号